Successful oral desensitization to trimethoprim-sulfamethoxazole in acquired immune deficiency syndrome (Q71812803)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8933778%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

Successful oral desensitization to trimethoprim-sulfamethoxazole in acquired immune deficiency syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8933778%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference

Kalanadhabhatta V

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8933778%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Muppidi D

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8933778%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Sahni H

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8933778%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Robles A

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8933778%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Kramer M

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8933778%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

publication date

1 November 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8933778%20AND%20SRC:MED&resulttype=core&format=json

Annals of Allergy, Asthma & Immunology

21 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8933778%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

77

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8933778%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8933778%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

394-400

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8933778%20AND%20SRC:MED&resulttype=core&format=json

Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS

21 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963338-8

7 January 2021

A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963338-8

7 January 2021

A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963338-8

7 January 2021

Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963338-8

7 January 2021

Use of low-dose trimethoprim-sulfamethoxazole thrice weekly for primary and secondary prophylaxis of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963338-8

7 January 2021

A comparison of the effectiveness of three regimens in the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963338-8

7 January 2021

Treatment of infections in patients with the acquired immunodeficiency syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963338-8

7 January 2021

Aerosolized pentamidine: effect on diagnosis and presentation of Pneumocystis carinii pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963338-8

7 January 2021

Pneumothorax in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963338-8

7 January 2021

Extrapulmonary Pneumocystosis: The First 50 Cases

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963338-8

7 January 2021

Once-a-month administration of intravenous pentamidine to patients infected with human immunodeficiency virus as prophylaxis for Pneumocystis carinii pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963338-8

7 January 2021

Prophylaxis for opportunistic infections in patients with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963338-8

7 January 2021

Utility of dapsone for prophylaxis of Pneumocystis carinii pneumonia in trimethoprim-sulfamethoxazole-intolerant, HIV-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963338-8

7 January 2021

Clindamycin/primaquine therapy and secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963338-8

7 January 2021

"Treating through" hypersensitivity to co-trimoxazole in AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963338-8

7 January 2021

Efficacy and safety of rechallenge with low-dose trimethoprim-sulphamethoxazole in previously hypersensitive HIV-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963338-8

7 January 2021

The acquired immunodeficiency syndrome and a trimethoprim-sulfamethoxazole adverse reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963338-8

7 January 2021

Oral desensitization to trimethoprim-sulfamethoxazole in a patient with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963338-8

7 January 2021

"Treating through" hypersensitivity to cotrimoxazole in children with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963338-8

7 January 2021

Sulphadiazine desensitization in patients with AIDS and cerebral toxoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963338-8

7 January 2021

Management of sulfadiazine allergy in patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963338-8

7 January 2021

Desensitization to trimethoprim/sulfamethoxazole in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963338-8

7 January 2021

Management of drug allergy in patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963338-8

7 January 2021

A TH1-->TH2 switch is a critical step in the etiology of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963338-8

7 January 2021

Drug-induced hepatotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963338-8

7 January 2021

Adverse Reactions to Trimethoprim-Sulfamethoxazole in Patients with the Acquired Immunodeficiency Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963338-8

7 January 2021

Detection of human IgE to sulfamethoxazole by skin testing with sulfamethoxazoyl-poly-L-tyrosine

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963338-8

7 January 2021

Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963338-8

7 January 2021

Induction of anergy or active suppression following oral tolerance is determined by antigen dosage.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963338-8

7 January 2021

Decreased efficacy of inhaled pentamidine in the prevention of Pneumocystis carinii pneumonia among HIV-infected patients with severe immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963338-8

7 January 2021

A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963338-8

7 January 2021

10.1016/S1081-1206(10)63338-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8933778%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference